What is Neurocrine Biosciences's finished goods?

Neurocrine Biosciences (NBIX) reported finished goods of $12.9M in Q1 2026.

How has Neurocrine Biosciences's finished goods changed year-over-year?

Neurocrine Biosciences's finished goods decreased by 5.1% year-over-year, from $13.6M to $12.9M.

What is the long-term trend for Neurocrine Biosciences's finished goods?

Over 5 years (2020 to 2025), Neurocrine Biosciences's finished goods has grown at a 9.7% compound annual growth rate (CAGR), from $9M to $14.3M.

Current Assets

Finished goods

Neurocrine Biosciences Finished goods decreased by 9.8% to $12.9M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.1%, from $13.6M to $12.9M. Over 5 years (FY 2020 to FY 2025), Finished goods shows an upward trend with a 9.7% CAGR.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

First reportedQ4 2019

Last reportedQ1 2026May 5, 2026

Parent metricInventories

Metric ID: inv_finished_goods

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$11.5M	$11.2M	$15.7M	$15.4M	$17.9M	$17M	$17.5M	$18M	$15M	$10.4M	$12.3M	$7.5M	$10.4M	$11.5M	$12.8M	$13.6M	$13.6M	$16.2M	$14.3M	$12.9M
QoQ Change	—	-2.6%	+40.2%	-1.9%	+16.2%	-5.0%	+2.9%	+2.9%	-16.7%	-30.7%	+18.3%	-39.0%	+38.7%	+10.6%	+11.3%	+6.3%	+0.0%	+19.1%	-11.7%	-9.8%
YoY Change	—	—	—	—	+55.7%	+51.8%	+11.5%	+16.9%	-16.2%	-38.8%	-29.7%	-58.3%	-30.7%	+10.6%	+4.1%	+81.3%	+30.8%	+40.9%	+11.7%	-5.1%
% of Inventories	40.6%	43.9%	51.5%	53.1%	61.1%	45.9%	49.9%	53.9%	47.3%	36.1%	28.3%	19.9%	23.8%	25.1%	22.3%	22.9%	23.8%	23.3%	20.7%	19.9%
Share Change	—	+3.3pp	+7.6pp	+1.6pp	+8.0pp	-15.1pp	+3.9pp	+4.0pp	-6.6pp	-11.2pp	-7.8pp	-8.3pp	+3.9pp	+1.3pp	-2.8pp	+0.6pp	+0.9pp	-0.5pp	-2.6pp	-0.7pp

Range$7.5M – $18M

CAGR+2.4%

Avg YoY Growth+8.5%

Median YoY Growth+11.0%

Current Streak2 quarters decline

Finished goods at Other Companies

BiogenBIIB View metric

ALN

Alnylam PharmaceuticalsALNY View metric

IncyteINCY View metric

ViatrisVTRS View metric

Eli LillyLLY View metric

ModernaMRNA View metric

Frequently Asked Questions

What is Neurocrine Biosciences's finished goods?: Neurocrine Biosciences (NBIX) reported finished goods of $12.9M in Q1 2026.
How has Neurocrine Biosciences's finished goods changed year-over-year?: Neurocrine Biosciences's finished goods decreased by 5.1% year-over-year, from $13.6M to $12.9M.
What is the long-term trend for Neurocrine Biosciences's finished goods?: Over 5 years (2020 to 2025), Neurocrine Biosciences's finished goods has grown at a 9.7% compound annual growth rate (CAGR), from $9M to $14.3M.